(Q44775459)

English

Efficacy and tolerability of the dorzolamide 2%/timolol 0.5% combination (COSOPT) versus 0.005% (XALATAN) in the treatment of ocular hypertension or glaucoma: results from two randomized clinical trials

scientific article published in February 2004

Statements

Efficacy and tolerability of the dorzolamide 2%/timolol 0.5% combination (COSOPT) versus 0.005% (XALATAN) in the treatment of ocular hypertension or glaucoma: results from two randomized clinical trials (English)
Robert D Fechtner
P Juhani Airaksinen
Albert J Getson
Christopher R Lines
Ingrid A Adamsons
COSOPT versus XALATAN Study Groups
1 February 2004

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit